Hana Levkovitz

1.5k total citations
24 papers, 1.2k citations indexed

About

Hana Levkovitz is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Hana Levkovitz has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Hana Levkovitz's work include Atherosclerosis and Cardiovascular Diseases (9 papers), Cholesterol and Lipid Metabolism (5 papers) and Magnesium in Health and Disease (4 papers). Hana Levkovitz is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (9 papers), Cholesterol and Lipid Metabolism (5 papers) and Magnesium in Health and Disease (4 papers). Hana Levkovitz collaborates with scholars based in Israel, United States and Russia. Hana Levkovitz's co-authors include Aviv Shaish, Dror Harats, Jacob George, Arnon Afek, Iris Goldberg, Boris Gilburd, Yehuda Shoenfeld, Elliott Sigal, Hiroki Kurihara and Mary A. Mulkins and has published in prestigious journals such as Circulation, PLoS ONE and Diabetes.

In The Last Decade

Hana Levkovitz

24 papers receiving 1.2k citations

Peers

Countries citing papers authored by Hana Levkovitz

Since Specialization

Citations

This map shows the geographic impact of Hana Levkovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hana Levkovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hana Levkovitz more than expected).

Fields of papers citing papers by Hana Levkovitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hana Levkovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hana Levkovitz. The network helps show where Hana Levkovitz may publish in the future.

Co-authorship network of co-authors of Hana Levkovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Hana Levkovitz. A scholar is included among the top collaborators of Hana Levkovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hana Levkovitz. Hana Levkovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins 2016 ·PLoS ONE ·Anat Boehm‐Cagan, (unknown), Dror Harats, Aviv Shaish, Hana Levkovitz, John K. Bielicki, Jan O. Johansson, Daniel M. Michaelson	26
2	The Antiatherogenic Effect of Allicin: Possible Mode of Action 2005 ·Pathobiology ·Ayelet Gonen, Dror Harats, Aharon Rabinkov, Talia Miron, David Mirelman, Meir Wilchek, Lev Weiner, (unknown), Hana Levkovitz, Dikla Ben‐Shushan, Aviv Shaish	81
3	Rosiglitazone (PPARγ‐agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes–atherosclerosis mouse model 2003 ·Diabetes Obesity and Metabolism ·Zohar Levi, Aviv Shaish, Niva Yacov, Hana Levkovitz, Svetlana Trestman, Yariv Gerber, Hillel W. Cohen, Addie Dvir, (unknown), M Ravid, Dror Harats	64
4	Atherogenesis Inhibition Induced by Magnesium-Chloride Fortification of Drinking Water 2002 ·Biological Trace Element Research ·Hofit Cohen, Yaniv Sherer, Aviv Shaish, Yehuda Shoenfeld, Hana Levkovitz, Rafael Bitzur, Dror Harats	15
5	Imaging of Aortic Atherosclerotic Lesions by <sup>125</sup>I-LDL, <sup>125</sup>I-Oxidized-LDL, <sup>125</sup>I-HDL and <sup>125</sup>I-BSA 2001 ·Pathobiology ·Aviv Shaish, Gad Keren, Pierre Chouraqui, Hana Levkovitz, Dror Harats	30
6	Tissue-specific gene therapy directed to tumor angiogenesis 2001 ·Gene Therapy ·Nira Varda‐Bloom, Aviv Shaish, Ayelet Gonen, Keren Levanon, (unknown), Sarah Ferber, Hana Levkovitz, David Castel, Iris Goldberg, Arnon Afek, (unknown), Dror Harats	62
7	Suppression of Atherogenesis in Female Low-Density Lipoprotein Receptor Knockout Mice following Magnesium Fortification of Drinking Water: The Importance of Diet 2000 ·Pathobiology ·Yaniv Sherer, Yehuda Shoenfeld, Aviv Shaish, Hana Levkovitz, Rafael Bitzur, Dror Harats	17
8	The Effect of Renin-Angiotensin Axis Inhibition on Early Atherogenesis in LDL-Receptor-Deficient Mice 2000 ·Pathobiology ·Yehonatan Sharabi, Ehud Grossman, Yaniv Sherer, Aviv Shaish, Hana Levkovitz, Rafael Bitzur, Dror Harats	4
9	The preproendothelin-1 promoter as a tool for specific gene therapy to angiogenic vascular endothelial cells 2000 ·Atherosclerosis ·Nira Varda‐Bloom, Aviv Shaish, Ayelet Gonen, Hana Levkovitz, Dror Harats	2
10	Allicin reduces atherosclerosis in mice and inhibits LDL Degradation in isolated mouse macrophages 2000 ·Atherosclerosis ·Aviv Shaish, David Mirelman, (unknown), Talia Miron, A. Rabinkov, Meir Wilchek, M. Eldar, Zvi Vered, Hana Levkovitz, Dror Harats	2
11	Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. 2000 ·Diabetes ·Pnina Keren, John George, Aviv Shaish, Hana Levkovitz, (unknown), Arnon Afek, Iris Goldberg, Juri Kopolovic, Gad Keren, Dror Harats	52
12	Magnesium Fortification of Drinking Water Suppresses Atherogenesis in Male LDL-Receptor-Deficient Mice 1999 ·Pathobiology ·Yaniv Sherer, Aviv Shaish, Hana Levkovitz, Pnina Keren, (unknown), Yehuda Shoenfeld, Dror Harats	20
13	Dietary β-Carotene and α-Tocopherol Combination Does Not Inhibit Atherogenesis in an ApoE–Deficient Mouse Model 1999 ·Arteriosclerosis Thrombosis and Vascular Biology ·Aviv Shaish, Jacob George, Boris Gilburd, Pnina Keren, Hana Levkovitz, Dror Harats	52
14	Magnesium fortifecation of drinking water suppresses atherogenesis in male LDL-receptor knockout mice 1999 ·Atherosclerosis ·Aviv Shaish, Yaniv Sherer, Hana Levkovitz, Yehuda Shoenfeld, Dror Harats	1
15	Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis 1998 ·Atherosclerosis ·Jacob George, Arnon Afek, Boris Gilburd, Hana Levkovitz, Aviv Shaish, Iris Goldberg, Yuri Kopolovic, Georg Wick, Yehuda Shoenfeld, Dror Harats	207
16	Induction of Early Atherosclerosis in LDL-Receptor–Deficient Mice Immunized With β ₂ -Glycoprotein I 1998 ·Circulation ·Jacob George, Arnon Afek, Boris Gilburd, Miri Blank, Yair Levy, Anabel Aron-Maor, Hana Levkovitz, Aviv Shaish, Iris Goldberg, Juri Kopolovic, Dror Harats, Yehuda Shoenfeld	167
17	1.P.10 Hyperimmunization of chow-fed ApoE deficient mice with homologous oxidized low density lipoprotein suppresses early atherogenesis 1997 ·Atherosclerosis ·Dror Harats, Jacob George, Arnon Afek, Boris Gilburd, Hana Levkovitz, Aviv Shaish, Iris Goldberg, Yuri Kopolovic, Yehuda Shoenfeld	5
18	Heparan sulfate-dependent and low density lipoprotein receptor-related protein-dependent catabolic pathways for lipoprotein lipase in mouse embryonic fibroblasts. 1996 ·PubMed ·Ephraim Sehayek, (unknown), Israël Vlodavsky, Rachel Avner, Hana Levkovitz, T. Olivecrona, Gunilla Olivecrona, (unknown), Joachim Herz, S Eisenberg	9
19	Binding to heparan sulfate is a major event during catabolism of lipoprotein lipase by HepG2 and other cell cultures 1995 ·Atherosclerosis ·Ephraim Sehayek, Thomas Olivecrona, Gunilla Bengtsson-Olivecrona, Israël Vlodavsky, Hana Levkovitz, Rachel Avner, Shlomo Eisenberg	16
20	Enhanced cellular metabolism of very low density lipoprotein by simvastatin. A novel mechanism of action of HMG‐CoA reductase inhibitors 1994 ·European Journal of Clinical Investigation ·Ephraim Sehayek, (unknown), Rachel Avner, Hana Levkovitz, S Eisenberg	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact